Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease
| Autor: | Frey, Aline, Trokan, Luba, Vogler, Markus, Hughes, Derralynn, Gimona, Alberto |
|---|---|
| Zdroj: | In Molecular Genetics and Metabolism February 2021 132(2):S39-S40 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect